301393 logo

Suzhou Highfine Biotech Co., Ltd. Stock Price

SZSE:301393 Community·CN¥5.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301393 Share Price Performance

CN¥0
-41.97 (-100.00%)
CN¥0
-41.97 (-100.00%)
Price CN¥0

301393 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

2 Risks
2 Rewards

Suzhou Highfine Biotech Co., Ltd. Key Details

CN¥558.4m

Revenue

CN¥347.2m

Cost of Revenue

CN¥211.2m

Gross Profit

CN¥74.2m

Other Expenses

CN¥137.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 17, 2026
1.28
37.82%
24.53%
0.4%
View Full Analysis

About 301393

Founded
2003
Employees
428
CEO
Yong Zhu
WebsiteView website
www.highfine.com

Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. The company’s products include building blocks, protein reagents, protein crosslinkers, peptide reagents, protective amino acids, ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, nucleotide reagents, etc. Its products are used in fields of peptide, nucleotide, and pharmaceutical synthesis. The company also exports its products. Suzhou Highfine Biotech Co., Ltd. was founded in 2003 and is based in Suzhou, China.

Recent 301393 News & Updates

Recent updates

No updates